Nestlé Health Science logo

Nestlé Health Science

Europe, Vaud, Switzerland, Vevey

Description

Nestlé Health Science is a company that uses nutrition to help people manage their health.

Investor Profile

Nestlé Health Science has backed more than 15 startups, with 0 new investments in the last 12 months alone. The firm has led 7 rounds, about 47% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series D, Post Ipo Equity, Series E rounds (top funding stages).
  • Majority of deals are located in United States, France, Switzerland.
  • Strong thematic focus on Health Care, Biotechnology, Life Science.

Stage Focus

  • Series D (27%)
  • Post Ipo Equity (20%)
  • Series E (13%)
  • Series Unknown (13%)
  • Debt Financing (7%)
  • Series C (7%)
  • Convertible Note (7%)
  • Private Equity (7%)

Country Focus

  • United States (47%)
  • France (27%)
  • Switzerland (13%)
  • China (7%)
  • New Zealand (7%)

Industry Focus

  • Health Care
  • Biotechnology
  • Life Science
  • Therapeutics
  • Biopharma
  • Pharmaceutical
  • Nutrition
  • Wellness
  • Primary And Urgent Care
  • Beauty
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Nestlé Health Science frequently co-invest with?

Omnes Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 2
Lundbeckfonden Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 3
Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Principia SGR
Europe, Lombardia, Italy, Milan
Co-Investments: 3
European Investment Bank
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 1
Climb Ventures
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1
Business Opportunities for L'Oréal Development
Europe, Ile-de-France, France, Clichy
Co-Investments: 1
HF
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Takeda
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1

What are some of recent deals done by Nestlé Health Science?

Timeline

Lausanne, Vaud, Switzerland

Timeline is an operator of a life science company aimed to sell goods that target mitochondrial health for enhanced nutrition.

BiotechnologyHealth CareNutritionWellness
Series DJan 17, 2024
Amount Raised: $64,783,848
Ruipeng Pet Healthcare

Shenzhen, Guangdong, China

Ruipeng Pet Hospital is a Shenzhen-based pet medical and beauty care hospital operator.

BeautyHealth CareHospitalMedical
Private EquityDec 23, 2022
ProciseDx

San Diego, California, United States

ProciseDx is a provider of point-of-care testing solutions for use in physician offices, retail clinics, and urgent care.

Health CarePrimary and Urgent Care
Convertible NoteJul 13, 2021
Amount Raised: $13,000,000
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Series EJun 25, 2020
Amount Raised: $51,939,777
Aimmune Therapeutics

Brisbane, California, United States

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquityFeb 5, 2020
Amount Raised: $200,000,000
Timeline

Lausanne, Vaud, Switzerland

Timeline is an operator of a life science company aimed to sell goods that target mitochondrial health for enhanced nutrition.

BiotechnologyHealth CareNutritionWellness
Series UnknownApr 2, 2019
Aimmune Therapeutics

Brisbane, California, United States

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquityNov 18, 2018
Amount Raised: $98,000,002
Axcella

Cambridge, Massachusetts, United States

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

BiotechnologyLife SciencePharmaceuticalTherapeutics
Series ENov 1, 2018
Amount Raised: $59,000,000
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Debt FinancingJan 4, 2018
Amount Raised: $48,266,625
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Series DJan 1, 2017
Amount Raised: $33,694,390

Find More Investors Like Nestlé Health Science

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Nestlé Health Science | Pipeseed